Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05479357
Other study ID # Soh-Med-22-07-02
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 28, 2022
Est. completion date December 30, 2022

Study information

Verified date July 2022
Source Sohag University
Contact Eman M Sabry, MBBCh
Phone +201012733125
Email emanmahmoud@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison between Carbetocin and Oxytocin as prophylaxis against Primary Postpartum Hemorrhage.


Description:

Patients will be allocated randomly by simple randomization into either 1- the control group which will be given 10 IU oxytocin intravenously, OR 2- the treatment group which will be given 100 micrograms of carbetocin intravenously. The trial will be conducted on patients with high risk of developing atonic primary postpartum hemorrhage. The trial will be single blinded. All patients fulfilling the inclusion criteria undergoing elective Caesarean section will be approached by the treating physician and will be asked to participate in the study. An informed written consent will be taken from each patient. The data collected will include base line characteristics such as age, parity, body mass index, the risk for Postpartum hemorrhage in each patient, amount of blood loss, blood units given, complete blood picture (pre and post operative) and coagulation profile.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date December 30, 2022
Est. primary completion date December 30, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - • High risk patients for post-partum hemorrhage who will subjected to Caeserean section either elective or in labour at or after 36 weeks of gestation. This should include one or more of the following: 1. History of postpartum hemorrhage. 2. Delivery of a macrosomic baby (> 4000 g). 3. Multiple gestation. 4. Polyhydramnios. 5. Grand Multiparity. 6. Interstitial or submucous fibroid. (Single larger than 4 cm or Multiple myomata) 7. Chorioamnionitis. Exclusion Criteria: - • Patients without high risk for post-partum hemorrhage. - Patients at high risk for postpartum hemorrhage but will deliver vaginally. - Patients with medical disorders complicating pregnancy. - Patients with coagulation defects. - Preterm pregnancies.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Oxytocin
10 iu will be given intravenously.
Carbetocin
100 micrograms will be given intravenously.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

References & Publications (12)

Brace V, Penney G, Hall M. Quantifying severe maternal morbidity: a Scottish population study. BJOG. 2004 May;111(5):481-4. — View Citation

Chong YS, Su LL, Arulkumaran S. Current strategies for the prevention of postpartum haemorrhage in the third stage of labour. Curr Opin Obstet Gynecol. 2004 Apr;16(2):143-50. Review. — View Citation

Dahlke JD, Mendez-Figueroa H, Maggio L, Hauspurg AK, Sperling JD, Chauhan SP, Rouse DJ. Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines. Am J Obstet Gynecol. 2015 Jul;213(1):76.e1-76.e10. doi: 10.1016/j.ajog.2015.02.023. Epub 2015 Feb 28. — View Citation

Girault A, Deneux-Tharaux C, Sentilhes L, Maillard F, Goffinet F. Undiagnosed abnormal postpartum blood loss: Incidence and risk factors. PLoS One. 2018 Jan 10;13(1):e0190845. doi: 10.1371/journal.pone.0190845. eCollection 2018. — View Citation

Lawrie TA, Rogozinska E, Sobiesuo P, Vogel JP, Ternent L, Oladapo OT. A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage. Int J Gynaecol Obstet. 2019 Jul;146(1):56-64. doi: 10.1002/ijgo.12836. Epub 2019 May 20. — View Citation

Maher MA, Sayyed TM, Elkhouly NI. Different routes and forms of uterotonics for treatment of retained placenta: a randomized clinical trial. J Matern Fetal Neonatal Med. 2017 Sep;30(18):2179-2184. doi: 10.1080/14767058.2016.1242124. Epub 2016 Oct 19. — View Citation

Mantel GD, Buchmann E, Rees H, Pattinson RC. Severe acute maternal morbidity: a pilot study of a definition for a near-miss. Br J Obstet Gynaecol. 1998 Sep;105(9):985-90. — View Citation

Nyfløt LT, Sandven I, Stray-Pedersen B, Pettersen S, Al-Zirqi I, Rosenberg M, Jacobsen AF, Vangen S. Risk factors for severe postpartum hemorrhage: a case-control study. BMC Pregnancy Childbirth. 2017 Jan 10;17(1):17. doi: 10.1186/s12884-016-1217-0. — View Citation

Nyfløt LT, Stray-Pedersen B, Forsén L, Vangen S. Duration of labor and the risk of severe postpartum hemorrhage: A case-control study. PLoS One. 2017 Apr 6;12(4):e0175306. doi: 10.1371/journal.pone.0175306. eCollection 2017. — View Citation

Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ. 2001 May 5;322(7294):1089-93; discussion 1093-4. — View Citation

Withanathantrige M, Goonewardene M, Dandeniya R, Gunatilake P, Gamage S. Comparison of four methods of blood loss estimation after cesarean delivery. Int J Gynaecol Obstet. 2016 Oct;135(1):51-5. doi: 10.1016/j.ijgo.2016.03.036. Epub 2016 Jul 4. — View Citation

Zhang WH, Alexander S, Bouvier-Colle MH, Macfarlane A; MOMS-B Group. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. BJOG. 2005 Jan;112(1):89-96. — View Citation

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Amount of Postpartum Hemorrhage Amount of Blood Loss in milliliters. Pre-operative patient's Hemoglobin (Hb) level and 24 hours post-operative will be assessed to quantify amount of blood loss. Additionally, all towels prepared for CS will weighed, and the weight will be marked on each pack before autoclaving. All towels (used and unused) will be weighed again after use, and a difference of 1 gm will be considered as equivalent to 1 mL of absorbed blood. First 24 hours after Delivery
See also
  Status Clinical Trial Phase
Completed NCT02627482 - Ambulatory Fetal Heart Rate Monitoring in Small Babies N/A
Active, not recruiting NCT03904979 - Therapeutic Writing to Reduce Stress N/A
Completed NCT02749851 - Placenta Imaging Project
Completed NCT03772080 - Prematurity Education in High Risk Pregnancies N/A
Recruiting NCT06151613 - Continuous Non-invasive Electrophysiological Monitoring in High Risk Pregnancies N/A
Enrolling by invitation NCT05763069 - HOME: Home Monitoring of High-risk Pregnancies
Completed NCT01708746 - Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views N/A
Not yet recruiting NCT04173559 - Sleep and Tracking Effects in Pregnancy Study N/A
Recruiting NCT03152058 - IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy Phase 2
Not yet recruiting NCT06320054 - Preventing Obstetric Complications With Dietary Intervention N/A
Recruiting NCT03220750 - University Hospital Advanced Age Pregnant Cohort N/A
Not yet recruiting NCT04855513 - Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial N/A
Recruiting NCT06414655 - Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
Completed NCT03082664 - Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients N/A
Recruiting NCT06279559 - Music Therapy and High-risk Pregnancy N/A
Recruiting NCT04203082 - Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries N/A
Completed NCT02379351 - Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring N/A
Recruiting NCT04783597 - Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies
Recruiting NCT06130150 - Sexual Function in High-risk Pregnant Women
Recruiting NCT03775954 - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise